Publication | Closed Access

In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China

Antimicrobial Drug DiscoveryExtended-spectrum β-LactamasesAntimicrobial SusceptibilityAntibioticsMedicineKlebsiella PneumoniaeBacteriologyEscherichia ColiMicrobiologyInfection ControlBacterial PathogensClinical MicrobiologyAntimicrobial Resistance